ANI Pharmaceuticals, Inc. - Common Stock — Flux de trésorerie (NASDAQ:ANIP) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Flux de trésorerie liés aux activités d'exploitation 15.27 M3.32 M-31.2 M118.96 M64.02 M185.22 M 208.61 M Flux de trésorerie liés aux activités d'investissement -68.32 M-105.48 M-15.74 M-18.51 M-404.72 M-34.32 M -25.8 M Flux de trésorerie liés aux activités de financement -1.44 M194.59 M-5.13 M67.44 M264.94 M-9.94 M -21.65 M Flux de trésorerie disponible 15.27 M3.32 M-31.2 M118.96 M64.02 M150.9 M 182.81 M

Nouvelles

Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term

ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook

ANIP Valuation: Does 9.8x Forward P/E Offer Upside?

ANIP Stock: What's Driving Cortrophin Gel's 2026 Surge

Un directeur d’ANI Pharmaceuticals cède des actions pour 1,13 million $

ANI Pharmaceuticals (ANIP) is a Top-Ranked Momentum Stock: Should You Buy?

ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised

Zacks.com featured highlights include ANI, Cummins and Seadrill

Le BPA de ANI Pharma a dépassé les attentes de 0,60$, le CA a surpassé les prévisions

3 Stocks Showing Powerful Earnings Acceleration This May

ANI Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ANIP) 2026-05-08

ANI Pharma T1 2026 : les maladies rares propulsent les revenus de 20%